CN Stock MarketDetailed Quotes

Suzhou Fushilai Pharmaceutical (301258)

Watchlist
  • 30.00
  • +0.12+0.40%
Market Closed Apr 30 15:00 CST
2.75BMarket Cap73.17P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Fushilai Pharmaceutical (301258) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Lipoic acid series270.66M62.55%
Carnosine series61.01M14.10%
艾瑞昔布52.8M12.20%
Phosphatidylcholine series42.7M9.87%
Other business5.55M1.28%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical main business427.18M98.72%
Other business5.55M1.28%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic234.3M54.14%
Abroad198.43M45.86%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -